For children with plaque psoriasis (6+) or ERA (4+) or PsA (2+) or AS (12+)
Pediatric Plaque Psoriasis
Kids and teens living with plaque psoriasis have a different option. If managing skin symptoms with creams, lotions, ointments or other remedies has been a struggle, you should consider COSENTYX® (secukinumab).
Enthesitis-Related Arthritis (ERA) and Juvenile Psoriatic Arthritis (JPsA)
Juvenile idiopathic arthritis is the most common form of arthritis in kids and teens and includes 7 types. COSENTYX treats two of them: ERA and JPsA.
Juvenile Ankylosing Spondylitis (JAS)
Ankylosing spondylitis (AS) is an inflammatory disease that includes pain and stiffness in the spine and may affect other joints. AS that starts before age 16 is known as juvenile ankylosing spondylitis (JAS). About 10-20% of people with AS begin to have symptoms during childhood. COSENTYX is approved to treat adults and children 12 years of age and older with active AS.
